Research Progress on the Anti-aging Effect of Young Plasma and its Mechanism

doi:10.3969/j.issn.1671-2587.2023.01.023

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2023, Vol. 25 ›› Issue (1): 137-142.DOI: 10.3969/j.issn.1671-2587.2023.01.023

Previous Articles Next Articles

Research Progress on the Anti-aging Effect of Young Plasma and its Mechanism

DU Ya-li, ZHANG Rong, WANG Yan-ju, et al

The Sixth Medical Center, Chinese PLA General Hospital, Department of Blood Transfusion, Beijing 100048

Received:2022-10-10 Published:2023-02-20

Abstract

Abstract: People are at increased risk for diabetes, cardiovascular disease, cancer and neurodegenerative diseases with age. Ingredient in young blood have become a new area of research for human longevity, disease treatment and prevention. In this paper, we carried out a detailed literature review for the effects of young blood on brain nerve, blood vessels, pancreas, liver, bone and the related mechanisms of application in old mice, so as to provide a reference value for the future of anti-aging research of young plasma in human.

Key words: Young plasma, Blood elements, Circulatory factor, Old mice, Senescence

CLC Number:

R457.1⁺4

DU Ya-li, ZHANG Rong, WANG Yan-ju, et al. Research Progress on the Anti-aging Effect of Young Plasma and its Mechanism[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 137-142.

References

[1] SAMERI S,SAMADI P,DEHGHAN R,et al.Stem cell aging in lifespan and disease:a state-of-the-art review[J]. Curr Stem Cell Res Ther,2020,15(4):362-378.
[2] YI SJ, KIM K.New Insights into the Role of Histone Changes in Aging[J]. Int J Mol Sci,2020,21(21):8241.
[3] MISHRA SK,BALENDRA V,ESPOSTO J,et al.Thera-peutic Antiaging Strategies[J]. Biomedicines,2022,10(10):2515.
[4] FESER J, TYLER J.Chromatin structure as a mediator of aging[J]. FEBS Lett,2011,585(13):2041-2048.
[5] HERNANDEZ-SEGURA A, NEHME J, DEMARIA M.Hallmarks of Cellular Senescence[J]. Trends Cell Biol,2018,28(6):436-453.
[6] BRUUNSGAARD H,ANDERSEN-RANBERG K,HJEL-MBORG J V B,et al. Elevated levels of tumor necrosis factor alpha and mortality in centenarians[J]. Am J Med,2003,115(4):278-283.
[7] KHOURY R,GHOSSOUB E.Young blood products:emerging treatment for Alzheimer's disease?[J]. Neural Regen Res,2018,13(4):624-627.
[8] KENIGSBUCH M,BOST P,HALEVI S,et al.A shared disease-associated oligodendrocyte signature among multiple CNS pathologies[J]. Nat Neurosci,2022,25(7):876-886.
[9] HOROWITZ A M,VILLEDA S A.Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease[J]. F1000Research,2017,6:1291.
[10] WYSS-CORAY T.Ageing,neurodegeneration and brain rejuvenation[J]. Nature,2016,539(7628):180-186.
[11] ZHAO Y,QIAN R,ZHANG J,et al.Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3 × Tg-AD mice[J]. Alzheimers Res Ther,2020,12(1):70.
[12] CONBOY M J,CONBOY I M,RANDO T A.Heterochronic parabiosis:historical perspective and methodological considerations for studies of aging and longevity[J]. Aging Cell,2013,12(3):525-530.
[13] SALPETER S J,KHALAILEH A,WEINBERG-COREM N,et al.Systemic regulation of the age-related decline of pancreatic β-cell replication[J]. Diabetes,2013,62(8):2843-2848.
[14] CONBOY I M,CONBOY M J,WAGERS A J,et al.Rejuvenation of aged progenitor cells by exposure to a young systemic environment[J]. Nature,2005,433(7027):760-764.
[15] BAHT G S,SILKSTONE D,VI L,et al.Exposure to a youthful circulaton rejuvenates bone repair through modulation of β-catenin[J]. Nat Commun,2015,6:7131.
[16] SHA S J,DEUTSCH G K,TIAN L,et al.Safety,tolera-bility,and feasibility of young plasma infusion in the plasma for alzheimer symptom amelioration study:a randomized clinical trial[J]. JAMA Neurol,2019,76(1):35-40.
[17] KISS T,TARANTINI S,CSIPO T,et al.Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice:transcriptional footprint of mitochondrial protection,attenuation of oxidative stress,and rescue of endothelial function by young blood[J]. GeroScience,2020,42(2):727-748.
[18] CHEN G Z,LIU Y,GOETZ R,et al.Α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling[J]. Nature,2018,553(7689):461-466.
[19] HU M C,SHI M J,MOE O W.Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters[J]. Pflugers Arch,2019,471(1):99-108.
[20] CHEN C D,LI Y X,CHEN A K,et al.Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho[J]. PLoS One,2020,15(1):e0226382.
[21] 2020 Alzheimer's disease facts and figures[J]. Alzheimer's Dement,2020,16(3):391-460.
[22] YANG K,WANG C,NIE L,et al.Klotho protects against indoxyl sulphate-induced myocardial hypertrophy[J]. J Am Soc Nephrol,2015,26(10):2434-2446.
[23] SAITO Y,NAKAMURA T,OHYAMA Y,et al.In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome[J]. Biochem Biophys Res Commun,2000,276(2):767-772.
[24] 严金华. 年轻血浆改善血管内皮细胞衰老作用及机制探究[D]. 武汉:华中科技大学,2018.
[25] WECHSLER A,BRAFMAN A,SHAFIR M,et al.Generation of viable cholesterol-free mice[J]. Science,2003,302(5653):2087.
[26] WU B J,CHEN K,SHRESTHA S,et al.High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1[J]. Circ Res,2013,112(2):278-288.
[27] LU X L,KAMBE F,CAO X,et al.3beta-Hydr-oxysteroid-delta24 reductase is a hydrogen peroxide scavenger,protecting cells from oxidative stress-induced apoptosis[J]. Endocrinology,2008,149(7):3267-3273.
[28] IZUMI M,MIZUNO T,YANAGI K I,et al.The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing[J]. J Biol Chem,2017,292(31):13008-13021.
[29] ZHANG Y H,WEI Y,LIU D,et al.Role of growth differentiation factor 11 in development,physiology and disease[J]. Oncotarget,2017,8(46):81604-81616.
[30] LI L,WEI X C,WANG D M,et al.Positive effects of a young systemic environment and high growth differentiation factor 11 levels on chondrocyte proliferation and cartilage matrix synthesis in old mice[J]. Arthritis Rheumatol,2020,72(7):1123-1133.
[31] JIN Q,QIAO C P,LI J B,et al.A GDF11/myostatin inhibitor,GDF11 propeptide-Fc,increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice[J]. Skelet Muscle,2019,9(1):16.
[32] SINHA M,JANG Y C,OH J,et al.Restoring sys-temic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science,2014,344(6184):649-652.
[33] ROCHETTE L,MALKA G.Neuroprotective poten-tial of GDF11:myth or reality?[J]. Int J Mol Sci,2019,20(14):3563.
[34] OZEK C,KROLEWSKI R C,BUCHANAN S M,et al.Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the Hippocampus of aged mice[J]. Sci Rep,2018,8(1):17293.
[35] LI H,LI Y X,XIANG L W,et al.GDF11 attenuates development of type 2 diabetes via improvement of islet β-cell function and survival[J]. Diabetes,2017,66(7):1914-1927.
[36] CASTELLANO J M,MOSHER K I,ABBEY R J,et al.Human umbilical cord plasma proteins revitalize hippocampal function in aged mice[J]. Nature,2017,544(7651):488-492.
[37] SCABIA G,TESTA G,SCALI M,et al.Reduced ccl11/eotaxin mediates the beneficial effects of environmental stimulation on the aged Hippocampus[J]. Brain Behav Immun,2021,98:234-244.
[38] YUAN JJ, ZHANG Q, GONG CX, et al.Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage[J].Biosci Rep,2019,39(5): BSR2019 0537.
[39] JEON OH,MEHDIPOUR M,GIL TH,et al.Systemic induction of senescence in young mice after single heterochronic blood exchange[J].Nat Metab,2022, 4(8):995-1006.
[40] CONESE M,CARBONE A,BECCIA E,et al.The Fountain of Youth: A Tale of Parabiosis, Stem Cells, and Rejuvenation. Open Med (Wars)[J].2017,12:376-383.

Research Progress on the Anti-aging Effect of Young Plasma and its Mechanism

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	HU Yan, ZHU Bang-qiang, WEN Hui-qin, et al. Lymphoplasmapheresis in ABO-incompatible Living Donor Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(5): 608-611.
[2]	ZHANG Jian, YAO Yong. A Comparison of the Refrigeration Effect of Two Types of Freezers [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(3): 271-272.
[3]	LIANG Ruo-hu, HUANG Yan, DENG Jin-lian, et al. A Feasibility Study on Preparation of Cryoprecipitation with Dewhite Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 134-137.
[4]	PEI De-cui, ZHENG Jin-xiu. Retrospective Analysis of Appropriateness and Effectiveness of Fresh Frozen Plasmaused [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 44-47.
[5]	ZHAO Guang-chao, LI Na, WANG Shu-jun, et al. Preparation and Effect Evaluation of Freeze-dried Cryoprecipitate [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(2): 199-201.
[6]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 99-99.
[7]	JI Rong-rong, ZHANG Xi-min, Kang-Na. A Preliminary Analysis of Abnormal Color of Donated Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(6): 553-555.
[8]	PAN Xue-qin, WANG Qing, HU Hai-liang, et al. An Observation on Blood Coagulation Indexes of Four Different Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(5): 444-446.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(2): 125-126.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2016, 18(6): 554-556.
[11]	DI Yan-hui, GUAN Hang, KOU Li-duo, et al. Serological Characteristics of Blood Group and Efficacy of Suspended Red Blood Cells Transfusion in Patients with Autoimmune Hemolytic Anemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(4): 455-458.